Abstract Background This study was conducted with descriptive design to determine the level of knowledge and quality of life of individuals suffering from coronary artery disease. Methods The study was…
Abstract Introduction Amyloidosis is a group of diseases characterized by the deposition of misfolded protein fragments, forming insoluble fibrils in organs and tissues. Transthyretin (ATTR) amyloidosis, particularly cardiac amyloidosis (CA),…
Atrial arrhythmia is the most common complication in the adult congenital heart disease population, and with an aging population, atrial fibrillation is rapidly increasing in prevalence—particularly in those with concomitant…
Atrioventricular nodal ablation (AVNA) represents a critical intervention in the management of refractory atrial fibrillation (AF) and heart failure (HF). When combined with biventricular pacing or conduction system pacing, particularly…
This article explores the existing knowledge regarding atrial fibrillation (AF) incidence, outcomes, and management in left ventricular assist device and orthotopic heart transplant patients as well as emerging technologies such…
End-stage heart failure (HF) accounts for 1% to 10% of all HF cases. It is frequently associated with coexistent atrial fibrillation due in part to structural changes related to altered…
Atrial fibrillation with Heart Failure is a constellation of co-morbid conditions that now constitutes a major cardiovascular epidemic, with HF now the most common complication of AF. Mechanistically, both conditions…
Atrial myopathy is the underlying pathophysiological substrate of atrial fibrillation and contributes to the risk of heart failure as well. Atrial myopathy is caused by classic risk factors such as…
Catheter ablation (CA) for atrial fibrillation (AF) in patients with heart failure with preserved ejection fraction (HFpEF) addresses the significant overlap of these conditions, often found in patients with comorbidities…
Multiple randomized clinical trials have demonstrated catheter ablation in heart failure with reduced ejection fraction reduces mortality and hospitalization as well as improves ventricular function, quality of life, and functional…
